In this study, the cisternal CSF contents of lactate and glucose were sequentially measured in free moving rats that had been administered probenecid, 200 mg/kg-I, drug diluent, or no injections. In animals re ceiving either no injections or injections of drug diluent, CSF lactate and glucose were constant over a 6-h period (93-106% of control), whereas rats receiving probenecid showed increased lactate at 1 and 2 h (170 and 125% con trol, respectively) and increased glucose at 1, 2, and 3 h (169, 141 and 129% control, respectively). Cerebral cortex content of energy metabolites and lactate and blood lactate levels were statistically unaltered at 0.5-6 h exposure to probenecid, whereas cerebral and blood glu cose contents were increased after I and 2 h exposure to probenecid. Rats exposed to 5% O2 and probenecid for
0.5 h showed a statistically higher CSF lactate at 0.5 and 1.5 h reoxygenation (169 and 168% control, respectively) . A similar effect was also seen in rats exposed to 5% O2 and the 5-hydroxyindoleacetic acid (5-HIAA) transport inhibitor Na divalproate. The results suggested that the increase in CSF glucose was secondary to a probenecid induced elevation of blood glucose, whereas the increase in CSF lactate seemed to be secondary to a reduced rate of efflux of lactate from the CSF. It is suggested that it may be possible to increase the CSF lactate content by mechanisms that are independent of direct effects on the processes of cerebral energy metabolism. Key Words: Probenecid-CSF lactate-Cerebral energy metabolism -Blood-brain transport.
monocarboxylic acids, such as lactate and proprio nate, from blood to brain. As the steady-state efflux rate of lactate from brain is estimated to be about 3 times that of influx (Pardridge et aI., 1975) , it is pos sible to postulate on the basis of the above data that probenecid administration could result in an in crease in the lactate content of the cerebrospinal (CSF) and extracellular fluid of the brain. The ob jective of the present study was to test this hy pothesis by direct measurement of the cisternal CSF lactate content of rats administered proben ecid. In addition, the cisternal CSF glucose content was measured for comparison of effects on another metabolite having a defined blood-brain carrier system. The study also includes a documentation of the effects of probenecid on cerebral energy metab olism and of the effects of probenecid and related drugs on CSF lactate in hypoxic animals,
METHODS

Animal preparation and experimental exposures
The experiments were performed on male rats of the Wistar strain (275-350 g) that were prepared with a per manent cannula in the cisterna magna, which allowed for repeated sampling of CSF in the free-moving animal (Sarna et a!., 1983) . About 3-5 days prior to experi mental use, animals were anesthetized with pentobarbital (65 mg/kg-I, i.p.) and placed in a head holder. The scalp was incised in the midline, and the posterior parietal skull was exposed. A burr hole was drilled in the midline 1-2 mm anterior to the external occipital crest and then a pp 10 polyethylene tube (Clay Adams, Parsippany, N.J., U.S.A.), containing an internal strut of fine wire, was passed through the dura and advanced along the under surface of the occipital bone to the cisterna magna-a distance of about 6-7 mm from the burr hole. The wire was then withdrawn, the flow of CSF confirmed, and the cannula secured in place with dental acrylic (Dentsply International, Inc., York, PA, U.S.A.). The cannula was then sealed with a removable cap made from a piece of pp 50 tubing. The procedure was well tolerated by the an imals and resulted in a preparation in which CSF could be repeatedly sampled over many days.
In the present study, animals had an initial CSF sample removed (35 f..d ), followed by intraperitoneal injection of probenecid (200 mg/kg-I) or equivalent volumes of dil uent (I M NaOH adjusted to pH 7.8 with phosphate buffer). CSF sampling was subsequently carried out at hourly intervals for 6 h. A third group was also studied in which CSF was sampled from animals receiving no injec tions. In the hypoxic study, animals prepared as above were placed for 0.5 h into a 7.5-L plastic chamber, through which 5% O2-95% N2 was passed at 2 Llmin-I. CSF samples were obtained prior to exposure, at 0.5 h exposure, and 0.5 and l.5 h after return to room air. In the cerebral metabolite series, animals were admin istered probenecid (200 mg/kg-I) or equivalent volumes of diluent, and brain sampling was carried out 0.5, 1, 2, and 6 h later. In order to facilitate brain sampling, animals were briefly anesthetized with 2% halothane, tracheoto mized, paralyzed with tubocurarine chloride, and venti lated with 30% O2-70% N20 on a rodent respirator. A femoral artery was cannulated for blood pressure re cording and arterial blood sampling. Brain freezing was carried out by pouring liquid nitrogen into a plastic funnel fitted to the skull (Ponten et aI., 1973) . The brain was removed from the frozen head and stored in a liquid ni trogen freezer until assay.
Analytical methods
The CSF contents of lactate and glucose were deter mined by the enzymatic fluorometric methods of Lowry and Passonneau (1972) . In these assays, a CSF sample of 35 ILl was added to 500 ILl 0.3 N perchloric acid con taining 1 mm ethylenediaminetetraacetate (EDTA) at O°C, followed by neutralization of supernatants with KOH-im idazole and KCl (Folbergrova et aI., 1972a) . Cerebral cortex samples for metabolic assay were prepared ac cording to the procedure of Folbergrova et a!. (l972a) and were assayed for ATP, ADP, AMP, phosphocreatine, cre atine, lactate, and glucose by enzymatic fluorometric methods (Lowry and Passonneau, 1972) . Arterial blood was processed as above and was analyzed for lactate and glucose.
Materials
Substrates and co-factors used in the fluorometric assay were obtained from Sigma Chemicals (St. Louis, MO, U.S.A.). Probenecid was also obtained from Sigma and was brought into solution with 1 M NaOH and ad justed to pH 7.8 with phosphate buffer prior to use (Sarna et aI., 1983) . Enzymes for fluorometric assay were ob tained from Boehringer Mannheim (Montreal, Canada). All other chemicals used were of analytical grade.
Calculations
Statistical analysis of results was carried out using Wil coxon's rank-sum test.
RESULTS
Behavioral effects
Animals receiving probenecid demonstrated a mildly lethargic behavior that lasted for about 1-1.5 h. No abnormalities of respiration or motor action were noted in these animals. Animals re ceiving injections of diluent demonstrated normal behavior. values for lactate in the three groups were statisti cally equivalent and gave a mean value of 2.33 ± 0.14 flmollml-l, which is slightly lower than the values of 2.5-3.0 flmol/ml-l usually reported for the rats' cisternal CSF (Folbergrova et aI., 1972b; MacMillan, 1977 MacMillan, , 1982a . As previous studies have involved acute anesthesia and surgical manipula tions, the present values may be more representa tive of the true in vivo CSF lactate content. An imals receiving either no injections or injections of diluent showed a remarkable stability of the cis ternal CSF lactate over the 6-h sampling period (i.e., 93-106% control), whereas animals receiving probenecid showed significant increases of 170 and 125% of control (p < 0.05) at 1 and 2 h, respec tively. Subsequent samplings at 3-6 h showed a re turn of lactate values to control values. The zero time values for glucose were also statistically equivalent in the three groups and gave a mean value of 3.72 ± 0.13 flmollml-I, which again is slightly lower than the values of 4-6 flmol/ml-l usually reported for the rats' cisternal CSF (Folber grova et aI., 1972b; MacMillan, 1982a MacMillan, , 1982b . In animals receiving either no injections or injections of diluent, the CSF glucose was very stable over the 6-h sampling period (i.e., 95-104% of control), whereas animals receiving probenecid showed mean increases of 169, 141, and 129% of control (p < 0.05) at 1, 2, and 3 h, respectively. Sampling at 4-6 h showed a return of glucose values to control levels.
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Physiological parameters and cerebral energy state
The values for arterial blood gases, pH, mean ar terial blood pressure, and body temperature in the diluent and probenecid experimental groups at the time of brain freezing indicated that the only statis tically significant difference was a mildly reduced arterial blood pH in the I-h probenecid group (7.30 ± 0.01 versus 7.36 ± 0.01 for diluent control; p < 0.05). This group also had a higher mean arterial Pe o2 value, which accounted in part for the re duced pH (40.8 ± 1.4 versus 36.7 ± 1.0 mm Hg for diluent control; p nonsignificant).
Ta ble 1 indicates that probenecid had no signifi cant effects on the cerebral contents of ATP, ADP, AMP, phosphocreatine, or creatine. The creatine/ phosphocreatine ratios were also statistically equivalent in the various diluent and probenecid groups and thus suggested the absence of a major intracellular acid -base difference or shift in the two groups.
Brain and blood lactate and glucose
The cerebral hemisphere contents of lactate were statistically equivalent in all four time groups after the administration of diluent or probenecid (Table  2 ). Blood lactate contents were also statistically equivalent in the various groups. Brain glucose content was increased in the 1-h and 2-h probenecid groups and was matched by similar increases in blood glucose at these sampling times. This pattern suggested that the increases in brain and CSF glu cose in probenecid animals was probably sec ondary to increased blood glucose.
CSF lactate in hypoxemia
Animals that received probenecid just prior to exposure to 5% O2 showed CSF lactate levels at 0.5 h that were equivalent to those seen in animals given diluent (Fig. 2) . During reoxygenation, pro benecid animals showed significantly higher CSF lactate contents at the 0.5-h and 1.5-h samplings (169 and 168% of diluent control, respectively).
The anticonvulsant n-dipropylacetate (valproic acid) is associated with dose-dependent increases Values are means ± SEM in f1mol/g-l.
a p < 0.05 compared to diluent control.
of CSF 5-HIAA and HVA content (MacMillan, 1979 (MacMillan, , 1985 , which suggests that it may have effects on CSF lactate that are similar to those of proben ecid. Figure 3 shows that animals pretreated with Na divalproate (500 mg/kg-I) had significantly higher CSF lactate levels at 0.5 and 1. 5 h of reoxy genation (166 and 182% of saline control, respec tively).
DISCUSSION
The results of the present study indicated that in addition to probenecid's well-documented ability to increase CSF 5-HIAA and HVA content (Guldberg et al., 1966; Korf and Van Praag, 1971; Van der Poel et al., 1977; Faull et al., 198 1) , it is also associated with increases in CSF lactate and glucose contents. The increases in CSF lactate could have been ex pected from previous studies that showed an inhibi tory effect of probenecid on endothelial monocar boxylic acid transport Yu wiler et aI., 1982) and from the suggestion that lactate shares with probenecid and 5-HIAA a common saturable carrier from brain to blood (Yu wiler et aI., 1982) . The increase in glucose was un expected, and as glucose has a transport system that is independent of the organic acid transporter (Oldendorf, 1973) , the initial CSF results could have signified that the observed effects of proben ecid on glucose and possibly lactate were either in dependent of its effect on transport or that proben ecid has a wider nonselective effect on a variety of carrier systems.
To be considered under noninhibition of trans port mechanisms, would be a primary effect of pro benecid on blood levels of glucose or lactate that could secondarily affect the brain extracellular and CSF contents. Thus, as the Km of the endothelial hexose carrier for glucose is about 9 mM (Pardridge et ai., 1975) , moderate increases in the normal blood glucose levels of 4-6 mM could result in in creased CSF glucose content. The study of Lewis et ai. (1974) illustrates this point by showing a di rect linear increase in CSF glucose as blood glucose is increased from 1 to 10 mM. The present demon stration that probenecid animals showed increased blood glucose at 1-h and 2-h exposure is in accor- dance with this mechanism being an explanation for the increased CSF glucose in the free-moving an imal. This was further supported by the simulta neous increases in cerebral tissue glucose seen at these times in these animals. As the Km for the en dothelial lactate carrier is relatively low (1. 9 mM) and approximates the normal plasma levels of lactic acid, this mechanism does not readily account for the increased CSF lactate (Pardridge and Olden dorf, 1977) . This prediction has been confirmed by direct experiments that have indicated a 3-6-h lag in CSF lactate elevation when blood levels were in creased from 2 to 8 mM (N emoto et a!., 1974) . In the present study, arterial blood lactate showed no significant increases that could account for the rather large increases in CSF lactate at the 1-2-h samplings.
In addition to effects on blood levels, probenecid could theoretically influence CSF lactate levels by a direct effect on the brain tissue production of lac tate. Examples of such effects are documented in the literature and include elevated lactate in hypo capnic alkalosis (MacMillan and Siesj6, 1973) and reduced lactate in hypercapnic acidosis (Folber grova et aI., 1972b) . The results of the present study, showing statistically unaltered tissue energy metabolites and lactate levels at 0.5-6 h of proben ecid exposure, seem adequate in ruling out a direct cerebral metabolic action as the explanation for the increased CSF lactate. Vol. 7, No.1, 1987 There are at least eight distinctive carrier systems that facilitate the trans endothelial trans port of metabolic substrates between blood and brain (Pardridge and Oldendorf, 1977) . Although in flux from blood to brain has been most easily studied and quantified, the available data generally suggest that some of the involved carrier systems have a capacity for bidirectional transport. The hexose carrier is completely bidirectional and sym metrical for glucose (Pard ridge and Oldendorf, 1975) , whereas the monocarboxylic acid carrier for lactate, although bidirectional, is asymmetric, with a threefold larger efflux than influx rate (Pardridge and Oldendorf, 1977) . The carrier for 5-HIAA and HVA appears to be totally asymmetric, as carrier mediated movement of these metabolites occurs only from brain to blood (Yuwiler et aI., 1982) . In previous studies, probenecid has been shown to have a strong inhibitory effect on the efflux of 5-HIAA, HV A, and other acidic metabolites of the cerebral monoamines (Guldberg et aI., 1966; Korf and Van Praag, 1971; Van Der Poel et a!., 1977; Faull et a!., 1981) and a moderate inhibitory effect on the influx of lactate via the endothelial monocar boxylic acid carrier (Pardridge et aI., 1975; Yuwiler et aI., 1982) . In addition, large doses of probenecid seem to have a moderate inhibitory effect on influx of glucose via the hexose carrier (see Ta ble 6, Par dridge et aI., 1975). Allowing for the bidirectional nature of the lactate carrier, the present results, showing increases of cisternal CSF lactate, are in agreement with an inhibitory action of probenecid on the carrier system mediating the efflux of this substance from the CSF. The inhibition of several carriers by one inhibitory agent has been pre viously documented by the observation that phlor etin inhibits both hexose and monocarboxylic acid transport into brain (Pardridge and Oldendorf, 1975) .
The present results suggested that it may be pos sible to manipulate the brain extracellular and CSF lactate content by administration of probenecid in a variety of physiological and pathological states. By way of example, Pardridge and Oldendorf (1977) have suggested that the restricted ability of the monocarboxylic acid carrier to remove lactate from the brain may be a basis for the selective vulnera bility of the brain to anoxia. By use of probenecid with various levels of hypoxia and ischemia, it may be possible to produce larger accumulations of lac tate or more prolonged exposures of brain to ele vated lactate levels and to thus test this and other theories that attribute a major pathogenetic role to lactacidosis in ischemic brain damage (see Plum, 1983) . The present studies showed that although probenecid administration prior to hypoxemia re sulted in no increase in the magnitude of CSF lac tate accumulation at 0.5-h exposure to 5% oxygen, it did result in a significantly delayed clearance of lactate from the CSF. Whether or not this prolonga tion of exposure to elevated CSF lactate levels has any pathological significance will require further di rect histological studies.
A number of drugs have actions similar to those of probenecid on the efflux of 5-HIAA and HVA from CSF. These include the anticonvulsants n-di propylacetate (MacMillan, 1979 (MacMillan, , 1985 , phenytoin (Chadwick et aI., 1975) , and the tranquilizer diaz epam (Chase et aI., 1970; MacMillan, 1985) . This suggests that they may also be associated with ele vation of CSF lactate levels under physiological and pathological states. This prediction was con firmed for n-dipropylacetate, which was associated with a prolonged clearance of CSF lactate in post hypoxemic animals. These preliminary results sug gest that a variety of drugs used in the resuscitative period after hypoxia-ischemia may have the po tential to prolong postischemic lactacidosis.
